Abiopharma

🔍 BURKE JAMES A (Director)

Company: Vistra Corp. (VST)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 2,200 shares of Common Stock at $135.99 per share (Direct)
  Date: 2026-08-31 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,141,887.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,465 shares of Common Stock at $135.25 per share (Direct)
  Date: 2026-09-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,146,352.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: H | shares_owned_after: 61,690.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: H | nature_of_ownership: By the James A. Burke 2012 Irrevocable Trust, dated 12/03/2012 | shares_owned_after: 34,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: H | nature_of_ownership: By the Marti E. Burke 2012 Irrevocable Trust, dated 10/16/2012 | shares_owned_after: 259.00

Footnotes:

• F1: Represents a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $135.92 to $136.00, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
• F2: Represents a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $135.00 to $135.50, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.